Free Trial

Knight Therapeutics (GUD) Insider Trading & Ownership

Knight Therapeutics logo
C$5.21 -0.01 (-0.19%)
(As of 05:28 PM ET)

Knight Therapeutics (TSE:GUD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
45.62%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
C$2.47 M
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
C$3.18 M
Get GUD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Knight Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GUD Insider Buying and Selling by Quarter

Knight Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/12/2024Sime ArmoyanInsiderBuy90,300C$5.13C$463,672.44
11/11/2024Samira SakhiaDirectorBuy20,000C$5.15C$103,000.00
9/16/2024Sime ArmoyanInsiderSell300,000C$6.13C$1,839,000.00
8/19/2024Amal KhouriSenior OfficerSell5,000C$5.78C$28,919.00
8/15/2024Amal KhouriSenior OfficerSell500C$5.75C$2,875.00
8/13/2024Amal KhouriSenior OfficerSell5,000C$5.75C$28,750.00
7/11/2024Amal KhouriSenior OfficerSell10,000C$5.70C$57,000.00
7/3/2024Amal KhouriSenior OfficerSell10,000C$5.72C$57,200.00
6/10/2024Amal KhouriSenior OfficerSell20,000C$5.80C$116,022.00
6/5/2024Jonathan Ross GoodmanDirectorBuy5,000C$5.80C$29,000.00
5/29/2024Robert Nathaniel LandeDirectorSell15,000C$5.91C$88,600.50
5/23/2024Robert Nathaniel LandeDirectorSell20,000C$5.94C$118,710.00
5/7/2024Sime ArmoyanInsiderSell15,000C$5.95C$89,250.00
4/11/2024Sime ArmoyanInsiderSell10,900C$5.95C$64,855.00
4/1/2024Sime ArmoyanInsiderBuy6,200C$5.25C$32,550.00
3/25/2024Sime ArmoyanInsiderBuy351,000C$5.25C$1,842,750.00
1/22/2024Sime ArmoyanInsiderSell28,200C$5.75C$162,150.00
1/19/2024Sime ArmoyanInsiderSell91,000C$5.75C$523,250.00
(Data available from 1/1/2013 forward)

GUD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Knight Therapeutics includes Amal Khouri, Janice Jean Murray, Jonathan Ross Goodman, Long Zone Holdings Inc. , Robert Nathaniel Lande, Samira Sakhia, and Sime Armoyan. Learn more on insiders at GUD.

45.62% of Knight Therapeutics stock is owned by insiders. Learn more on GUD's insider holdings.

The following insiders have purchased GUD shares in the last 24 months: Jonathan Ross Goodman (C$29,000.00), Samira Sakhia (C$103,000.00), and Sime Armoyan (C$2,459,495.04).

Insiders have purchased a total of 500,000 GUD shares in the last 24 months for a total of C$2,591,495.04 bought.

The following insiders have sold GUD shares in the last 24 months: Amal Khouri (C$290,766.00), Robert Nathaniel Lande (C$207,310.50), and Sime Armoyan (C$2,678,505.00).

Insiders have sold a total of 530,600 Knight Therapeutics shares in the last 24 months for a total of C$3,176,581.50 sold.

Knight Therapeutics Key Executives

  • Mr. Jonathan Ross Goodman B.A. (Age 55)
    L.L.B., M.B.A., Executive Chairman
    Compensation: $250.94k
  • Ms. Samira Sakhia BCom (Age 56)
    CA, CPA, MBA, President, CEO & Director
    Compensation: $674.28k
  • Mr. Arvind Utchanah
    Chief Financial Officer
  • Ms. Amal Khouri B.Sc.
    M.B.A., Chief Business Officer
  • Mr. Jeff Martens
    Global Vice President of Commercial
  • Mr. Stephani Saverio
    Vice President of Business Development
  • Mr. Leopoldo Bosano
    Vice-President of Manufacturing & Operations
  • Ms. Monica Percario
    Global Vice President of Scientific Affairs
  • Mr. Henrique Dias
    Global Director of Marketing
  • Ms. Susan Caroline Emblem
    Global Vice President of Human Resources


This page (TSE:GUD) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners